Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 2.600
-0.230 (-8.13%)
May 9, 2025, 4:14 PM CET
Arctic Bioscience AS Revenue
In the year 2024, Arctic Bioscience AS had annual revenue of 44.40M NOK with 31.55% growth. Arctic Bioscience AS had revenue of 17.20M in the half year ending June 30, 2024, with 19.46% growth.
Revenue
44.40M
Revenue Growth
+31.55%
P/S Ratio
1.56
Revenue / Employee
2.61M
Employees
355
Market Cap
69.39M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 537.23M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Nykode Therapeutics AS | 104.04M |
| Hofseth BioCare ASA | 265.54M |
| Omda AS | 426.27M |
| Gentian Diagnostics ASA | 158.07M |